Exhibit 4.1 Advisory and Consulting Agreement Number of Shares and Options ---------------------------- 4.1(a) as amended 11,150,000Consulting Agreement • May 25th, 2001 • Kaire Holdings Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 25th, 2001 Company Industry Jurisdiction